Autonomic Dysfunction: A Driving Force for Myocardial Fibrosis in Young Duchenne Muscular Dystrophy Patients?

被引:37
|
作者
Thomas, Tamara O. [1 ]
Jefferies, John L. [1 ]
Lorts, Angela [1 ]
Anderson, Jeffrey B. [1 ]
Gao, Zhiqian [1 ]
Benson, D. Woodrow [2 ]
Hor, Kan N. [3 ]
Cripe, Linda H. [3 ]
Urbina, Elaine M. [1 ]
机构
[1] Cincinnati Childrens Hosp Med Ctr, Inst Heart, Cincinnati, OH 45229 USA
[2] Childrens Hosp Wisconsin, Dept Pediat, Milwaukee, WI 53226 USA
[3] Nationwide Childrens Hosp, Dept Pediat, Columbus, OH 43205 USA
关键词
Duchenne; Cardiomyopathy; Myocardial fibrosis; Heart rate variability; Tachycardia; HEART-RATE-VARIABILITY; FREQUENCY-DOMAIN MEASURES; CIRCUMFERENTIAL STRAIN; DILATED CARDIOMYOPATHY; CARDIAC DYSFUNCTION; PERIOD VARIABILITY; INFARCTION; FAILURE; TIME;
D O I
10.1007/s00246-014-1050-z
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Cardiac manifestations of Duchenne muscular dystrophy (DMD) include progressive cardiac dysfunction and an elevated resting heart rate (HR). We hypothesized this elevated HR reflects autonomic dysfunction that can be identified by heart rate variability (HRV) analyses which will be associated with myocardial fibrosis by cardiac magnetic resonance imaging (cMR). DMD patients (N = 74) and controls (N = 17) had time and frequency domain HRV analyses calculated via Holter monitoring. Cardiac magnetic resonance imaging was performed on DMD cases only. chi (2) test, T test, ANOVA, and logistic regression were used to perform comparisons between groups. A p value of < 0.05 was used for statistical significance. DMD cases had higher resting average HR than controls (99.4 +/- A 8.9, 85.4 + 6.2, p < 0.001). Among HRV variables, decreases were seen in the following: standard deviation of R to R intervals, the percent RR intervals differing by > 50 ms from previous RR interval, the root-meansquare of successive differences of RR intervals, the standard deviation of the mean R to R segment (SDANN), low frequency, and high frequency domain, all p values 0.001. Maximum HR and SDANN most significantly associated with positive LGE on cMR (p = 0.008, p = 0.016). DMD cases on beta blocker had an average HR lower than those not on beta blocker (p = 0.009), but with no difference in HRV analysis. DMD patients have reduced HRV and therefore autonomic dysfunction prior to the onset of heart failure which is associated with myocardial fibrosis.
引用
收藏
页码:561 / 568
页数:8
相关论文
共 50 条
  • [41] PTX3 Predicts Myocardial Damage and Fibrosis in Duchenne Muscular Dystrophy
    Farini, Andrea
    Villa, Chiara
    Di Silvestre, Dario
    Bella, Pamela
    Tripodi, Luana
    Rossi, Rossana
    Sitzia, Clementina
    Gatti, Stefano
    Mauri, Pierluigi
    Torrente, Yvan
    FRONTIERS IN PHYSIOLOGY, 2020, 11
  • [42] Early Myocardial Dysfunction and Benefits of Cardiac Treatment in Young X-Linked Duchenne Muscular Dystrophy Mice
    Vincenti, Marie
    Farah, Charlotte
    Amedro, Pascal
    Scheuermann, Valerie
    Lacampagne, Alain
    Cazorla, Olivier
    CARDIOVASCULAR DRUGS AND THERAPY, 2022, 36 (05) : 793 - 803
  • [43] Early Myocardial Dysfunction and Benefits of Cardiac Treatment in Young X-Linked Duchenne Muscular Dystrophy Mice
    Marie Vincenti
    Charlotte Farah
    Pascal Amedro
    Valerie Scheuermann
    Alain Lacampagne
    Olivier Cazorla
    Cardiovascular Drugs and Therapy, 2022, 36 : 793 - 803
  • [44] Targeting fibrosis and inflammation in Duchenne Muscular Dystrophy
    Preusse, C.
    Goebel, H. H.
    von Moers, A.
    Heppner, F. L.
    Stenzel, W.
    NEUROMUSCULAR DISORDERS, 2013, 23 (9-10) : 839 - 839
  • [45] Understanding the Process of Fibrosis in Duchenne Muscular Dystrophy
    Kharraz, Yacine
    Guerra, Joana
    Pessina, Patrizia
    Serrano, Antonio L.
    Munoz-Canoves, Pura
    BIOMED RESEARCH INTERNATIONAL, 2014, 2014
  • [46] Left ventricular strain-volume loops and myocardial fibrosis in pediatric patients with Duchenne muscular dystrophy
    Kerstens, Thijs P.
    van Everdingen, Wouter M.
    ten Cate, Floris E. A. Udink
    Thijssen, Dick H. J.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2024, 395
  • [47] Telomere and Mitochondrial Dysfunction in Duchenne Muscular Dystrophy
    Chang, Alex C.
    Ong, Sang-Ging
    Wu, Joseph
    Blau, Helen M.
    CIRCULATION RESEARCH, 2015, 117
  • [48] Decoding Dysfunction in Duchenne Muscular Dystrophy Cardiomyopathy
    Reza, Nosheen
    Owens, Anjali T.
    CIRCULATION-GENOMIC AND PRECISION MEDICINE, 2018, 11 (01): : E002051
  • [49] Progressive left ventricular dysfunction and myocardial fibrosis in Duchenne and Becker muscular dystrophy: a longitudinal cardiovascular magnetic resonance study
    Aikawa, Tadao
    Takeda, Atsuhito
    Oyama-Manabe, Noriko
    Naya, Masanao
    Yamazawa, Hirokuni
    Koyanagawa, Kazuhiro
    Ito, Yoichi M.
    Anzai, Toshihisa
    PEDIATRIC CARDIOLOGY, 2019, 40 (02) : 384 - 392
  • [50] Microtubules Underlie Dysfunction in Duchenne Muscular Dystrophy
    Khairallah, Ramzi J.
    Shi, Guoli
    Sbrana, Francesca
    Prosser, Benjamin L.
    Borroto, Carlos
    Mazaitis, Mark J.
    Hoffman, Eric P.
    Mahurkar, Anup
    Sachs, Fredrick
    Sun, Yezhou
    Chen, Yi-Wen
    Raiteri, Roberto
    Lederer, W. Jonathan
    Dorsey, Susan G.
    Ward, Christopher W.
    SCIENCE SIGNALING, 2012, 5 (236)